1. bookVolume 70 (2021): Issue 1 (June 2021)
Journal Details
License
Format
Journal
eISSN
2247-059X
First Published
31 Jan 1951
Publication timeframe
1 time per year
Languages
English
access type Open Access

COVID-19 complicated by multiple germs infection -case report and short literature review

Published Online: 28 May 2022
Volume & Issue: Volume 70 (2021) - Issue 1 (June 2021)
Page range: 45 - 50
Journal Details
License
Format
Journal
eISSN
2247-059X
First Published
31 Jan 1951
Publication timeframe
1 time per year
Languages
English
Abstract

Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is characterised by a varied clinical picture. In some cases the evolution may be unfavourable, progressing to pneumonia and acute respiratory distress syndrome.

Clinical case: A 70-years-old woman, with multiple comorbidities, was admitted for low-grade fever, dry cough and loss of appetite, symptoms that started 4 days prior to hospitalisation. She was initially diagnosed with mild coronavirus disease 2019 (COVID-19). On the 18th day of illness, there was an increase in inflammatory markers, progression of radiological lesions and SpO2 dropped to 88% room air. Treatment with tocilizumab, remdesivir and high-flow oxygen therapy was initiated. Chest Computed tomography with pulmonary artery angiography ruled out suspected pulmonary embolism, but revealed a new pneumonic process and right pleural effusion, therefore antibiotic therapy was started. Imaging reassessment revealed excavation of the pneumonic process and persistence of pleural effusion. Reverse transcription polymerase chain reaction (RT-PCR) retesting for SARSCOV2 was negative and the patient was transferred to another hospital to undergo bronchoscopy and continue the treatment. Bacteriological examination of the induced sputum revealed the presence of Stenotrophomonas maltophilia, and in the bronchial aspirate was isolated Legionella pneumophilla; whereas the pharyngeal exudate highlighed the presence of Candida glabrata. Finally, the evolution was favorable. The patient was discharged with the recommendation to continue antibiotic therapy at home.

Conclusions: The evolution of SARS-CoV-2 infection may be unpredictable, the superinfection with other pathogens may influence the prognosis and progression of the disease.

Keywords

1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses; Gorbalenya AE, Baker SC. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology. 2020;5(4): 536–544.10.1038/s41564-020-0695-zSearch in Google Scholar

2. WHO Director-General’s opening remarks at the media briefing on COVID-19: 11 March 2020. Published March 11, 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-oncovid-19---11-march-2020 [Accessed 26th December 2020].Search in Google Scholar

3. World Health Organization. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 [Accessed on 26 December 2020].Search in Google Scholar

4. Ordinul nr. 1.418 din 7 august 2020 privind modificarea anexei la Ordinul Ministrului Sănătății, nr. 487/2020 pentru aprobarea protocolului de tratament al infecției cu virusul SARS-Cov-2. In: Monitorul Oficial al României. Partea I, nr. 242 din 24 martie 2020, Available from: http://legislatie.just.ro/Public/DetaliiDocument/229019 [Accessed 26th December 2020].Search in Google Scholar

5. Slavcovici A, Streinu-Cercel A, Ţăţulescu D, Radulescu A, Mera S, Marcu C, et al. The role of risk factors ‘carmeli score’ and infective endocarditis classification in the assessment of appropriate empirical therapy. Therapeutics, Pharmacology and Clinical Toxicology. 2009;13(1): 52–56.Search in Google Scholar

6. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13): 1239–1242.10.1001/jama.2020.2648Search in Google Scholar

7. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323(16): 1574–1581.10.1001/jama.2020.5394Search in Google Scholar

8. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229): 1054–1062.10.1016/S0140-6736(20)30566-3Search in Google Scholar

9. Garcia-Vidal C, Sanjuan G, Moreno-Garcia E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clinical Microbiology and Infection. 2021;27(1): 83–88.10.1016/j.cmi.2020.07.041Search in Google Scholar

10. Xing Q, Li GJ, Xing YH, Chen T, Li WJ, Ni W, et al. Precautions are needed for COVID-19 patients with coinfection of common respiratory pathogens. medRxiv.Search in Google Scholar

11. Chen, Nanshan; Zhou, Min; Dong, Xuan; Qu, Jieming; Gong, Fengyun; Han, Yang; Qiu, Yang; Wang, Jingli; Liu, Ying; Wei, Yuan; Xia, Jia’an; Yu, Ting; Zhang, Xinxin; Zhang, Li (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, S0140673620302117–. https://doi.org/10.1016/S0140-6736(20)30211-710.1016/S0140-6736(20)30211-7Search in Google Scholar

12. Yiqi Fu, Qing Yang, Min Xu, Haishen Kong, Hongchao Chen, Yajie Fu, Yake Yao, Hua Zhou, Jianying Zhou, Secondary Bacterial Infections in Critical Ill Patients With Coronavirus Disease 2019, Open Forum Infectious Diseases, Volume 7, Issue 6, June 2020, ofaa220, https://doi.org/10.1093/ofid/ofaa22010.1093/ofid/ofaa220731376232613024Search in Google Scholar

13. Bassetti, M., Kollef, M.H. & Timsit, JF. Bacterial and fungal superinfections in critically ill patients with COVID-19. Intensive Care Med 46, 2071–2074 (2020). https://doi.org/10.1007/s00134-020-06219-810.1007/s00134-020-06219-8747999832902729Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo